文献速递烧伤创面修复

PermeaDerm与Mepilex Ag治疗部分厚度烧伤的随机对照试验

A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns.
PubMed 文献 · J Burn Care Res · 2025-01-01

尽管14天和21天愈合率差异无统计学意义,但PermeaDerm组产品更换需求显著更低(OR 0.15,P=0.034),疼痛、美观和不良事件两组相似。

要点

  • PermeaDerm与Mepilex Ag在14天和21天愈合率上无显著差异。
  • PermeaDerm组产品更换需求显著低于Mepilex Ag组(OR 0.15,P=0.034)。
  • 两组疼痛评分、美观效果及不良事件(包括感染)相似。

核心结论

  • PermeaDerm是治疗部分厚度烧伤安全有效的方法,具有透明可持续监测创面和黏附减少更换需求的临床优势。

主要发现

  • 14天愈合率PermeaDerm组高于Mepilex Ag组但无统计学意义(P=0.36),浅二度损伤亚组OR 5.87(P=0.203,95%CI 0.385-89.580)。
  • 21天愈合率趋势持续(P=0.25)。
  • 7天愈合率Mepilex Ag组高于PermeaDerm组但无统计学意义(P=0.25)。
  • PermeaDerm组产品更换需求显著低于Mepilex Ag组(OR 0.15,P=0.034,95%CI 0.027-0.872)。
  • 转换为替代治疗的时间、总体疼痛评分、美观和不良事件(包括感染)两组无显著差异。

关键数值与推荐

  • 纳入标准:部分厚度烧伤<30% TBSA,72小时内治疗。
  • 主要结局:14天100%再上皮化发生率和转换为替代治疗的时间。
  • 次要结局:7天和21天愈合发生率、疼痛、产品更换次数和不良事件。

临床怎么用

  • PermeaDerm可用于部分厚度烧伤,透明特性便于持续监测创面,黏附性减少产品更换需求,72小时后可沐浴。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A next-generation transparent biosynthetic wound matrix (PermeaDerm) was developed for the treatment of burn injuries. Improvements include slits in an outer 2D silicone epidermal analog allowing for customizable moisture control, and an updated biocoating of the nylon knitted fabric to optimize wound adherence. The purpose of this randomized, single-blinded, multicenter trial was to compare PermeaDerm to a commonly used silver-containing foam dressing (Mepilex Ag) for the treatment of partial-thickness burns. Patients with partial-thickness burns <30% TBSA treated within 72 hours were included. Primary outcomes included incidence of 100% re-epithelialization at 14 days and time to conversion to alternative therapy. Secondary outcomes included incidence of healing at 7 and 21 days, pain, number of product changes, and adverse events. Sixty-seven patients (42 pediatric, 25 adult) were analyzed, 32 with Mepilex Ag and 35 with PermeaDerm. Though not statistically significant, more patients achieved healing with PermeaDerm at day 14 (P = 0.36), particularly those with superficial partial-thickness injuries (OR 5.87, P = 0.203, 95% CI = 0.385, 89.580). This trend continued to day 21 (P = 0.25). At day 7, nonsignificant increased incidence of healing of Mepilex Ag-treated wounds was observed (P = 0.25), in addition, PermeaDerm was associated with lower needs for product changes (OR 0.15, P = 0.034, 95% CI = 0.027, 0.872); both observations likely attributable to the adherent nature of PermeaDerm. No significant differences in time to conversion to alternate therapies were noted. Overall pain scores, aesthetics, and adverse events, including infection, were similar between groups. PermeaDerm is a safe and effective treatment for partial-thickness burns. PermeaDerm offers the clinical advantages of being transparent to continuously monitor the wound and adherent, reducing the need for a product change and allowing for bathing after 72 hours.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Greenhalgh DG, Hill DM, Velamuri R, et al. A Randomized, Controlled Trial Comparing PermeaDerm to Mepilex Ag for the Treatment of Adult and Pediatric Partial-Thickness Burns. J Burn Care Res. 2025. PMID: 40341353. doi:10.1093/jbcr/iraf013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。